Published in Women's Health Weekly, July 22nd, 2004
According to a recent study in the journal Luminescence, "Use of antisense nucleic acids to modulate expression of particular genes is a promising approach to the therapy of HPV-16-associated cervical cancer. Understandably, evaluation of the in vivo performance of synthetic AS-ODNs or ribozymes is of ultimate importance to development of effective antisense tools.
"Here we report the use...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly